Henry Schein (HSIC) Corporate presentation summary

Business overview and market position

• Leading global provider of dental merchandise, specialty products, equipment, and services, with $13.2B in FY2025 global net sales and operations in 34 countries.

• Serves over 1 million customers and employs more than 25,000 team members.

• Holds #1 market share in dental distribution in the US, Canada, Europe, Australia/New Zealand, and Brazil.

• Diversified sales: 84% from distribution and value-added services, 11% from specialty products, and 5% from technology.

• Component of the S&P 500 Index for 9 years.

Strategic transformation and growth initiatives

• BOLD + 1 strategy focuses on transforming into a more agile, digital, high-growth, high-margin company.

• High-growth, high-margin businesses now account for ~25% of sales and ~47% of non-GAAP operating income.

• Goal to exceed 50% of non-GAAP operating income from high-growth, high-margin businesses by 2027.

• Strategic priorities include expanding specialty and technology offerings, operational efficiencies, and digital transformation.

• Active M&A pipeline targets bolt-on acquisitions in software, specialty, and services businesses.

Financial performance and capital allocation

• Net sales grew from $584M in 1995 to $13.2B in 2025, an 11% CAGR.

• 2025 non-GAAP operating income reached $972M, with a 7.37% margin.

• Diluted non-GAAP EPS for 2025 was $4.97, up 4.9% from 2024.

• Strong cash flow supports investments and share repurchases; $712M operating cash flow in 2025.

• Disciplined capital allocation prioritizes organic growth, M&A, operational efficiency, and shareholder returns.